Author:
Terezakis Stephanie,Plastaras John P.
Publisher
Springer International Publishing
Reference64 articles.
1. Terezakis S, Hudson MM, Constine LS. Hodgkin’s disease. In: Halperin EC, Constine LS, Tarbell NJ, Kun LE, editors. Pediatric radiation oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2011. p. 137–65.
2. Jerusalem G, Warland V, Najjar F, et al. Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Nucl Med Commun. 1999;20(1):13–20.
3. Gallamini A, Rigacci L, Merli F, et al. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin’s disease. Haematologica. 2006;91(4):475–81.
4. Hutchings M, Loft A, Hansen M, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood. 2006;107(1):52–9.
5. Moskowitz AJ, Yahalom J, Kewalramani T, et al. Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Blood. 2010;116(23):4934–7.